Source: PRWeb

Press Release: BioCircuit Technologies : BioCircuit Technologies Announces First Human Implants of Nerve Tape

Surgeons across the US are now using Nerve Tape to achieve sutureless nerve repair ATLANTA, June 6, 2024 /PRNewswire-PRWeb/ -- BioCircuit Technologies®, a leader in medical device innovation, is proud to announce the first human implantations of Nerve Tape, the first FDA-approved device...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Michelle Jarrard's photo - CEO of BioCircuit Technologies

CEO

Michelle Jarrard

CEO Approval Rating

- -/100